A

Andrew S. Mendiola

Gladstone Institutes

ORCID: 0000-0002-2897-3299

Publishes on Neuroinflammation and Neurodegeneration Mechanisms, Retinal Diseases and Treatments, Chemokine receptors and signaling. 40 papers and 1.9k citations.

PubIndex Score97Top 3% · mid-careerHow it's scored

40Publications

1.9kTotal Citations

First publication: 2013First senior author: 2024

Neuroinflammation and Neurodegeneration Mechanisms Retinal Diseases and Treatments Chemokine receptors and signaling Atherosclerosis and Cardiovascular Diseases Alzheimer's disease research and treatments

Top publicationsby citations

The IL-1β phenomena in neuroinflammatory diseases

Andrew S. Mendiola, Astrid E. Cardona|Journal of Neural Transmission|2017

Cited by 301

Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration

Jae Kyu Ryu, Katerina Akassoglou, Victoria A. Rafalski et al.|Nature Immunology|2018

Cited by 210

Fibrinogen Activates BMP Signaling in Oligodendrocyte Progenitor Cells and Inhibits Remyelination after Vascular Damage

Mark A. Petersen, Katerina Akassoglou, Jae K. Lee et al.|Neuron|2017

Cited by 206

Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation

Andrew S. Mendiola, Katerina Akassoglou, Jae Kyu Ryu et al.|Nature Immunology|2020

Cited by 202

The Role of Microglia in Diabetic Retinopathy

Jeffery Grigsby, Astrid E. Cardona, Sandra M. Cardona et al.|Journal of Ophthalmology|2014

Cited by 191